On the daily chart, BHEL has started trading below the 20-day SMA, which is a sign of weakness. At present, the stock is outperforming the benchmark indices.
Sun Pharma has made a decent correction from the 'double top' level of Rs 1080 to Rs 940 and has been consolidating around these levels for quite some time.
Aurobindo Pharma on the weekly chart has decisively broken out above the medium term 'falling channel' at Rs 485 with strong bullish candle indicating a positive bias.